These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
350 related items for PubMed ID: 14578141
1. Segregation analysis of 231 Ashkenazi Jewish families for evidence of additional breast cancer susceptibility genes. Kaufman DJ, Beaty TH, Struewing JP. Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1045-52. PubMed ID: 14578141 [Abstract] [Full Text] [Related]
3. Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and Bloom syndrome mutations in Ashkenazi Jewish population: possible role in risk modification for cancer development. Koren-Michowitz M, Friedman E, Gershoni-Baruch R, Brok-Simoni F, Patael Y, Rechavi G, Amariglio N. Am J Hematol; 2005 Mar; 78(3):203-6. PubMed ID: 15726604 [Abstract] [Full Text] [Related]
4. The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Satagopan JM, Offit K, Foulkes W, Robson ME, Wacholder S, Eng CM, Karp SE, Begg CB. Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):467-73. PubMed ID: 11352856 [Abstract] [Full Text] [Related]
11. High incidence of BRCA1-2 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinoma. Biron-Shental T, Drucker L, Altaras M, Bernheim J, Fishman A. Eur J Surg Oncol; 2006 Dec; 32(10):1097-100. PubMed ID: 16650962 [Abstract] [Full Text] [Related]
12. Concomitant BRCA1 and BRCA2 gene mutations in an Ashkenazi Jewish woman with primary breast and ovarian cancer. Spannuth WA, Thaker PH, Sood AK. Am J Obstet Gynecol; 2007 Apr; 196(4):e6-9. PubMed ID: 17403394 [Abstract] [Full Text] [Related]
15. Genetic variation in IGF-1 and breast cancer risk in Ashkenazi carriers and noncarriers of BRCA1/2 mutations. Khoury-Shakour S, Lejbkowicz F, Barnett-Griness O, Tamir A, Pinchev M, Rennert G. Eur J Cancer Prev; 2009 Sep; 18(5):361-7. PubMed ID: 19543094 [Abstract] [Full Text] [Related]
16. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives. Cao AY, Huang J, Hu Z, Li WF, Ma ZL, Tang LL, Zhang B, Su FX, Zhou J, Di GH, Shen KW, Wu J, Lu JS, Luo JM, Yuan WT, Shen ZZ, Huang W, Shao ZM. Breast Cancer Res Treat; 2009 May; 115(1):51-5. PubMed ID: 18483852 [Abstract] [Full Text] [Related]
17. Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000. Tryggvadottir L, Sigvaldason H, Olafsdottir GH, Jonasson JG, Jonsson T, Tulinius H, Eyfjörd JE. J Natl Cancer Inst; 2006 Jan 18; 98(2):116-22. PubMed ID: 16418514 [Abstract] [Full Text] [Related]
18. Segregation analysis of breast cancer in a population-based sample of postmenopausal probands: The Iowa Women's Health Study. Chen PL, Sellers TA, Rich SS, Potter JD, Folsom AR. Genet Epidemiol; 1995 Jan 18; 12(4):401-15. PubMed ID: 8536957 [Abstract] [Full Text] [Related]
19. Screening for a BRCA2 rearrangement in high-risk breast/ovarian cancer families: evidence for a founder effect and analysis of the associated phenotypes. Machado PM, Brandão RD, Cavaco BM, Eugénio J, Bento S, Nave M, Rodrigues P, Fernandes A, Vaz F. J Clin Oncol; 2007 May 20; 25(15):2027-34. PubMed ID: 17513806 [Abstract] [Full Text] [Related]